| Glutathione as a marker for human disease G Teskey, R Abrahem, R Cao, K Gyurjian, H Islamoglu, M Lucero, ... Advances in clinical chemistry 87, 141-159, 2018 | 203 | 2018 |
| General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus K To, R Cao, A Yegiazaryan, J Owens, V Venketaraman Journal of clinical medicine 9 (8), 2541, 2020 | 162 | 2020 |
| Association between telomere length and diabetes mellitus: A meta-analysis J Wang, X Dong, L Cao, Y Sun, Y Qiu, Y Zhang, R Cao, M Covasa, ... Journal of International Medical Research 44 (6), 1156-1173, 2016 | 145 | 2016 |
| The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis G Teskey, R Cao, H Islamoglu, A Medina, C Prasad, R Prasad, ... Frontiers in immunology 9, 2069, 2018 | 44 | 2018 |
| Characterizing the effects of glutathione as an immunoadjuvant in the treatment of tuberculosis R Cao, G Teskey, H Islamoglu, R Abrahem, S Munjal, K Gyurjian, L Zhong, ... Antimicrobial Agents and Chemotherapy 62 (11), 10.1128/aac. 01132-18, 2018 | 38 | 2018 |
| Antimycobacterial effects of everolimus in a human granuloma model D Ashley, J Hernandez, R Cao, K To, A Yegiazaryan, R Abrahem, ... Journal of Clinical Medicine 9 (7), 2043, 2020 | 33 | 2020 |
| Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity R Cao, G Teskey, H Islamoglu, M Gutierrez, O Salaiz, S Munjal, MP Fraix, ... Molecules 24 (5), 851, 2019 | 21 | 2019 |
| Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in … K To, R Cao, A Yegiazaryan, J Owens, T Nguyen, K Sasaninia, C Vaughn, ... Frontiers in Cellular and Infection Microbiology 11, 657775, 2021 | 19 | 2021 |
| Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection H Islamoglu, R Cao, G Teskey, K Gyurjian, S Lucar, MP Fraix, ... Journal of Clinical Medicine 7 (3), 40, 2018 | 18 | 2018 |
| Cyclic Peptide [R4W4] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas J Hernandez, D Ashley, R Cao, R Abrahem, T Nguyen, K To, ... Frontiers in Immunology 11, 1677, 2020 | 11 | 2020 |
| Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs N Kachour, A Beever, J Owens, R Cao, A Kolloli, R Kumar, K Sasaninia, ... Antioxidants 11 (4), 673, 2022 | 10 | 2022 |
| The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against Mycobacterium bovis BCG Strain in Individuals with … K To, R Cao, A Yegiazaryan, J Owens, K Sasaninia, C Vaughn, M Singh, ... Biomolecular concepts 12 (1), 16-26, 2021 | 9 | 2021 |
| Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione R Abrahem, R Cao, B Robinson, S Munjal, T Cho, K To, D Ashley, ... Journal of Clinical Medicine 8 (10), 1556, 2019 | 9 | 2019 |
| The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type … R Cao, H Islamoglu, G Teskey, K Gyurjian, R Abrahem, OK Onajole, ... International Microbiology 23, 161-170, 2020 | 8 | 2020 |
| Liposomes as carriers for the delivery of efavirenz in combination with glutathione—an approach to combat opportunistic infections V Kenchappa, R Cao, V Venketaraman, GV Betageri Applied Sciences 12 (3), 1468, 2022 | 7 | 2022 |
| Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection R Cao, A Kolloli, R Kumar, J Owens, K Sasaninia, C Vaughn, M Singh, ... Applied Sciences 11 (17), 8274, 2021 | 7 | 2021 |
| The pathogenesis of tuberculosis-diabetes comorbidity G Teskey, R Cao, S Cerni, L Chang, K Fahmy, J Geiger, T Halbert, ... MRA 5 (12), 1613, 2017 | 7 | 2017 |
| Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection R Cao, K To, N Kachour, A Beever, J Owens, A Sathananthan, P Singh, ... Biomolecular concepts 12 (1), 46-54, 2021 | 4 | 2021 |
| 1 型糖尿病, 2 型糖尿病及 2 型糖尿病伴动脉硬化患者外周血白细胞端粒长度的研究 王建飞， 董旭， 张毅， 曹丽， 曹若琼， 孙阳阳， 王建国， 钟理， 王君， 边志颖 中国病理生理杂志 32 (6), 1066-1070, 2016 | 3 | 2016 |
| LIPOSOMAL FORMULATION OF REDUCED GLUTATHIONE DECREASES BACTERIAL LOAD AND ALTERS THE IMMUNE RESPONSE IN MYCOBACTERIUM TUBERCULOSIS INFECTION N Kachour, A Beever, J Owens, R Cao, A Kalloli, R Kumar, K Sasaninia, ... JOURNAL OF INVESTIGATIVE MEDICINE 70 (1), 322-322, 2022 | | 2022 |
Vishwanath VenketaramanProfessor and Discipline lead for Microbiology and Immunology在 westernu.edu 的电子邮件经过验证
